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Background:  Preeclampsia occurs in 3-5% of pregnancies and may have important consequences for future maternal health, with an increased 
risk to develop cardiovascular disease. The best approach for targeting primary prevention in these young women is yet unclear. We sought to 
investigate the prevalence of cardiovascular risk factors in women at 10 years post preeclampsia in comparison with a reference group of women 
with normal pregnancies.
Methods:  Women with a history of early preeclampsia (hypertension ≥ 140/ 90 mmHg with proteinuria ≥ 0.3 gram/ 24 before 32 weeks of 
gestation) and an equal number of age-matched women after uncomplicated pregnancy, drawn from the obstetric database at our hospital (1991 
and 2005), were sent a questionnaire and were invited for a cardiovascular screening programme consisting of a physical examination, ECG and 
laboratory measurements.
Results:  A total number of 339 exposed women (64% response rate) and 332 women from the reference group (41% response rate) were willing 
to participate. Mean age at the screening visit was 38.6 (SD±4.4) years for the exposed group and 39.6 (SD±4.9) years for the reference group 
(p=0.24). Both systolic (SBP) and diastolic (DBP) blood pressures were significantly higher in women after preeclampsia compared with women 
in the reference group (SBP 127 vs 119 mmHg, DBP 86 vs 79 mmHg, p<0.001). Hypertension, defined as SBP ≥140mmHG or DBP ≥90mmHg or 
use of antihypertensive medication, was present in 43.1% of exposed women versus 17.2% of women in the reference group. Adjusted odds ratio 
for hypertension was 3.32 (95%CI 2.26-4.87) in exposed women. BMI was not different between both groups, however waist circumference was 
significantly higher in women after preeclampsia compared with the reference group (86.6 vs 83.4 cm, p=0.01). Fasting lipid- and glucose levels 
were not different between both groups. Proteinuria (> 0.15 g/L) was present in 10.7% of women after preeclampsia compared to 5.9% of women in 
reference group (p = 0.02).
Conclusions:  We found a high prevalence of hypertension (with signs of proteinuria) in young women at ten years post early preeclampsia. An 
early approach for screening and treatment of hypertension is needed in these women.
